Literature DB >> 23909724

Association of urinary phytoestrogen concentrations with serum concentrations of prostate-specific antigen in the National Health and Nutrition Examination Survey.

Esther Walser-Domjan1, Aline Richard, Monika Eichholzer, Elizabeth A Platz, Jakob Linseisen, Sabine Rohrmann.   

Abstract

Some clinical trials have shown that high phytoestrogen intake may decrease serum concentrations of prostate-specific antigen (PSA), and phytoestrogens may also lower prostate cancer risk. It was the aim of this study to examine the relationship between the serum PSA level and urine phytoestrogen concentration in generally healthy U.S. men. Eight hundred twenty-four men, 40+ yr old without prostate cancer, who participated in the 2001-2004 NHANES surveys, were included in the analysis. The association of total PSA, free PSA, and PSA ratio [free PSA/total PSA * 100] with concentrations of isoflavones and lignans (standardized for urinary creatinine concentration) was examined using multivariable-adjusted linear and logistic regression models. The linear regression analyses showed no clear association between creatinine-standardized urinary phytoestrogen concentrations and serum total or free PSA levels or PSA ratio. However, the odds of having a PSA ratio <15% rose from Quartile 1 to Quartile 4 of isoflavone excretion (odds ratio = 2.82, 95% confidence interval 1.28-6.22 for top vs. bottom quartile), but there were no associations with having a PSA ratio <25%. In generally healthy U.S. men, 40+ yr old without a diagnosis of prostate cancer, urinary isoflavone, and lignan concentrations were not associated with serum PSA level.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23909724      PMCID: PMC4086485          DOI: 10.1080/01635581.2013.801999

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  48 in total

1.  Meta-analysis of soy food and risk of prostate cancer in men.

Authors:  Lin Yan; Edward L Spitznagel
Journal:  Int J Cancer       Date:  2005-11-20       Impact factor: 7.396

2.  Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase.

Authors:  Alan R Kristal; Chen Chi; Catherine M Tangen; Phyllis J Goodman; Ruth Etzioni; Ian M Thompson
Journal:  Cancer       Date:  2006-01-15       Impact factor: 6.860

Review 3.  Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.

Authors:  Roger Chou; Jennifer M Croswell; Tracy Dana; Christina Bougatsos; Ian Blazina; Rongwei Fu; Ken Gleitsmann; Helen C Koenig; Clarence Lam; Ashley Maltz; J Bruin Rugge; Kenneth Lin
Journal:  Ann Intern Med       Date:  2011-10-07       Impact factor: 25.391

4.  Serum prostate-specific antigen but not testosterone levels decrease in a randomized soy intervention among men.

Authors:  G Maskarinec; Y Morimoto; S Hebshi; S Sharma; A A Franke; F Z Stanczyk
Journal:  Eur J Clin Nutr       Date:  2006-06-14       Impact factor: 4.016

5.  C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer.

Authors:  Steven Lehrer; Edward J Diamond; Boris Mamkine; Michael J Droller; Nelson N Stone; Richard G Stock
Journal:  BJU Int       Date:  2005-05       Impact factor: 5.588

6.  Urinary phytoestrogen concentrations in the U.S. population (1999-2000).

Authors:  Liza Valentín-Blasini; Melissa A Sadowski; Donna Walden; Lisa Caltabiano; Larry L Needham; Dana B Barr
Journal:  J Expo Anal Environ Epidemiol       Date:  2005-11

7.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  Andrew S Levey; Kai-Uwe Eckardt; Yusuke Tsukamoto; Adeera Levin; Josef Coresh; Jerome Rossert; Dick De Zeeuw; Thomas H Hostetter; Norbert Lameire; Garabed Eknoyan
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

8.  The distribution of serum prostate-specific antigen levels among American men: implications for prostate cancer prevalence and screening.

Authors:  Michael P Porter; Janet L Stanford; Paul H Lange
Journal:  Prostate       Date:  2006-07-01       Impact factor: 4.104

9.  [Pharmacological potential of phytoestrogens in the treatment of prostate cancer].

Authors:  P Thelen; F Seseke; R-H Ringert; W Wuttke; D Seidlová-Wuttke
Journal:  Urologe A       Date:  2006-02       Impact factor: 0.639

10.  Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.

Authors:  H Gilbert Welch; Lisa M Schwartz; Steven Woloshin
Journal:  J Natl Cancer Inst       Date:  2005-08-03       Impact factor: 13.506

View more
  1 in total

Review 1.  Isoflavones and Prostate Cancer: A Review of Some Critical Issues.

Authors:  Hong-Yi Zhang; Jie Cui; Ye Zhang; Zhen-Long Wang; Tie Chong; Zi-Ming Wang
Journal:  Chin Med J (Engl)       Date:  2016-02-05       Impact factor: 2.628

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.